DELCATH SYSTEMS, INC.
Surgical & Medical Instruments & Apparatus · 566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
官方登记数据
0位关注者
1988成立于
关于 DELCATH SYSTEMS, INC.
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Source: Wikipedia
行业Surgical & Medical Instruments & Apparatus
总部566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
成立1988
法律形式C Corporation
状态营业中
专利26 项专利
APPARATUS FOR REMOVING CHEMOTHERAPY COMPOUNDS FROM BLOODEP2776086A4 · 2016
Filter and Frame Apparatus and Method of UseUS2016193401A1 · 2016
关键数据
法律信息
| 法定名称 | DELCATH SYSTEMS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 872912在 SEC EDGAR 上查看 ↗ |
| EIN | 06-1245881 |
| 行业代码(SIC) | 3841 |
| 注册地址 | 566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
566 QUEENSBURY AVENUE, QUEENSBURY, NY 12804
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面